- Integumen Plc (SKIN) has signed multi-year contracts with two Top ten global cosmetic companies.
- The agreements have been signed for periodic LabskinAI services, and as per the basis of contract the R&D teams in the US, the EU and Asia will connect and collaborate with the LabskinAI virtual lab.
- The company has already received the initial aggregate low six-figure payments for the data-driven engagements.
- On 7th October 2019, at the time of writing, GMT 08:03 AM, SKIN shares were trading at GBX 1.75, up by 0.04 points or 2.35% against the previous day closing price.
With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities.
Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?
Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.
We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.